OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0
Anna C. Pavlick, Charlotte E. Ariyan, Elizabeth I. Buchbinder, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 10, pp. e006947-e006947
Open Access | Times Cited: 23

Showing 23 citing articles:

Topical transdermal administration of lenalidomide nanosuspensions-based hydrogels against melanoma: In vitro and in vivo studies
Meng‐Di Zhang, Haiying Qiu, Zheyi Han, et al.
International Journal of Pharmaceutics X (2025) Vol. 9, pp. 100316-100316
Closed Access | Times Cited: 1

Cutaneous melanoma
Alpaslan Tasdogan, Ryan J. Sullivan, Alexander Katalinic, et al.
Nature Reviews Disease Primers (2025) Vol. 11, Iss. 1
Closed Access | Times Cited: 1

Access to melanoma drugs in Spain: a cross-sectional survey
María González‐Cao, Teresa Puértolas, José Luís Manzano, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 10, pp. 2572-2583
Closed Access | Times Cited: 4

Real‐world management of patients with complete response under immune‐checkpoint inhibition for advanced melanoma
Markus Reitmajer, Elisabeth Livingstone, Kai‐Martin Thoms, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2025)
Open Access

Role of Surgery for Metastatic Melanoma in the Era of Checkpoint Blockade
Vennila Padmanaban, Carlo M. Contreras
Surgical Clinics of North America (2025)
Closed Access

Risk score stratification of cutaneous melanoma patients based on whole slide images analysis by deep learning
Céline Bossard, Yahia Salhi, Amir Khammari, et al.
Journal of the European Academy of Dermatology and Venereology (2025)
Closed Access

An MGRN1-Based Biomarker Combination Accurately Predicts Melanoma Patient Survival
José Sánchez-Beltrán, Juan Postigo Díaz, Cecilia Herráiz, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1739-1739
Open Access

Real‐world management bei Patienten mit Komplettremission unter Immuncheckpoint‐Inhibition bei fortgeschrittenem Melanom
Markus Reitmajer, Elisabeth Livingstone, Kai‐Martin Thoms, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2025) Vol. 23, Iss. 3, pp. 321-329
Open Access

Prognostic utility of the CALLY index in metastatic melanoma: building a nomogram for Patients on Anti-PD-1 therapy
Caner Acar, Haydar Çağatay Yüksel, Gökhan Şahin, et al.
Clinical & Translational Oncology (2025)
Open Access

C-reactive protein kinetics as prognostic biomarkers in advanced melanoma treated with immune checkpoint inhibitors
Caner Acar, Haydar Çağatay Yüksel, Gökhan Şahin, et al.
Melanoma Research (2025)
Closed Access

CD24, NFIL3, FN1, and KLRK1 signature predicts melanoma immunotherapy response and survival
Bruna Pereira Sorroche, Renan de Jesus Teixeira, Vinícius Gonçalves de Souza, et al.
Journal of Molecular Medicine (2025)
Closed Access

Pre-existing Autoimmune Diseases and Immune Checkpoint Inhibitors for Cancer Treatment: Considerations About Initiation, Flares, Immune-Related Adverse Events, and Cancer Progression
Jeffrey A. Sparks
Rheumatic Disease Clinics of North America (2024) Vol. 50, Iss. 2, pp. 147-159
Closed Access | Times Cited: 3

Artificial intelligence and skin melanoma
N. J. Levell, Lucy Thomas
Clinics in Dermatology (2024) Vol. 42, Iss. 5, pp. 460-465
Closed Access | Times Cited: 2

Melanoma extracellular vesicles inhibit tumor growth and metastasis by stimulating CD8 T cells
Yuxi Dan, Jing Ma, Yuqing Long, et al.
Molecular Immunology (2024) Vol. 169, pp. 78-85
Closed Access | Times Cited: 1

Treatment strategies with electrochemotherapy for limb in-transit melanoma: real-world outcomes from a European, retrospective, cohort study
L Campana, Francesca Tauceri, Joana Bártolo, et al.
European Journal of Surgical Oncology (2024), pp. 108740-108740
Closed Access | Times Cited: 1

Rate of response to immune checkpoint inhibitor therapy in patients with conjunctival melanoma
Bita Esmaeli, Tyler Ogden, Matthew Nichols, et al.
Melanoma Research (2024)
Closed Access | Times Cited: 1

Tissue-Agnostic Cancer Therapy Approvals
Mohamed A. Gouda, Vivek Subbiah
Surgical Oncology Clinics of North America (2023) Vol. 33, Iss. 2, pp. 243-264
Closed Access | Times Cited: 2

Real-World efficiency of pembrolizumab in metastatic melanoma patients following adjuvant anti-PD1 treatment
Michael Weichenthal, Inge Marie Svane, Johanna Mangana, et al.
EJC Skin Cancer (2024) Vol. 2, pp. 100271-100271
Closed Access

Atypical localization of metastatic melanoma in the gastrointestinal tract
María Orts, Daniel Abad Pérez
Revista Española de Enfermedades Digestivas (2024)
Open Access

Dual PD-L1/SOX10 Immunohistochemistry Combined With Digital Imaging Enhances Stratification Accuracy of Patients With Metastatic Melanoma
Juan Pineda-Reyes, Sri Krishna Chaitanya Arudra, Phyu P. Aung, et al.
The American Journal of Surgical Pathology (2024) Vol. 48, Iss. 12, pp. 1551-1556
Closed Access

Efficacy and prognostic factors of anti-PD1 and nivolumab-ipilimumab therapy in advanced melanoma patients resistant to prior ICI treatment
Caner Acar, Haydar Çağatay Yüksel, Gökhan Şahin, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access

COORDENAÇÃO DO CUIDADO NO ÂMBITO DO RASTREAMENTO DO CÂNCER DE MAMA E COLO DO ÚTERO
Brenda Freitas Pontes, Jane Baptista Quitete, Mariana Tavares da Silva, et al.
Enfermagem em Foco (2024) Vol. 15
Closed Access

Page 1

Scroll to top